Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Net Cash Flow (2016 - 2026)

Standard Biotools has reported Net Cash Flow over the past 16 years, most recently at -$8.6 million for Q4 2025.

  • Quarterly Net Cash Flow rose 79.91% to -$8.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$46.4 million through Dec 2025, down 139.59% year-over-year, with the annual reading at -$46.4 million for FY2025, 139.59% down from the prior year.
  • Net Cash Flow was -$8.6 million for Q4 2025 at Standard Biotools, up from -$29.0 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $235.9 million in Q1 2024 and troughed at -$62.5 million in Q3 2023.
  • The 5-year median for Net Cash Flow is -$15.7 million (2025), against an average of -$90789.5.
  • Year-over-year, Net Cash Flow plummeted 581.95% in 2021 and then skyrocketed 1885.84% in 2023.
  • A 5-year view of Net Cash Flow shows it stood at -$39.2 million in 2021, then soared by 153.05% to $20.8 million in 2022, then plummeted by 235.52% to -$28.2 million in 2023, then crashed by 52.06% to -$42.9 million in 2024, then skyrocketed by 79.91% to -$8.6 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Net Cash Flow are -$8.6 million (Q4 2025), -$29.0 million (Q3 2025), and $6.9 million (Q2 2025).